Simotang Alleviates the Gastrointestinal Side Effects of Chemotherapy by Altering Gut Microbiota

키워드

참고문헌 (54)

1. Padraic Smith, "An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management", Best Practice & Research Clinical Gastroenterology, 48-49, pp.101691~ (2020), Elsevier BV[DOI]
2. Herrstedt J, "Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting", Expert Opin. Drug Saf, 3, pp.231~248 (2004)[DOI]
3. "Palonosetron" (2022)[URL]
4. "Aprepitant Side Effects" (2022)[URL]
5. "Dexamethasone Side Effects" (2022)[URL]
6. "Metoclopramide Side Effects" (2022)[URL]
7. Li M, "Research progress in pharmacology and clinical application of Simotang oral liquid", Zhongnan Pharmaceutical, 12, pp.2031~2036 (2020)
8. Chen SP, "Effect of Simotang oral liquid on anal exhaust in patients after abdominal gynecological operation", Chin. J. Integr. Med, 12, pp.221~223 (2006)
9. Hu Y, "Effect of Chinese patent medicine Si-Mo-Tang oral liquid for functional dyspepsia : A systematic review and meta-analysis of randomized controlled trials", PLoS One, 12, pp.e0171878~ (2017)
10. Cai GX, "Simotang enhances gastrointestinal motility, motilin and cholecystokinin expression in chronically stressed mice", World J. Gastroenterol, 17, pp.1594~1599 (2011)
11. Wang HM, "Influence of Simotang oral liquid on gastrointestinal responses of the patients with adjuvant chemotherapy after the surgery of gastric cancer", Western J. Trad. Chinese Med, 27, pp.84~86 (2014)
12. Sun CT, "Study on the protective effect of Simo Tang on gastrointestinal tract injury caused by radio-chemotherapy in cervical cancer", Pharm. Clin. Chinese Mater. Medica, 7, pp.62~63 (2016)[DOI]
13. Shen N, "Protective effect of Simo Tang on the gastrointestinal function of endostar combined with paclitaxel liposome-treated cervical cancer patients and effect on the serum IL-8, CEA CA125 levels", Progress Modern Biomed, 18, pp.935~938 (2018)[DOI]
14. Feng W, "Gut microbiota, a new frontier to understand traditional Chinese medicines", Pharmacol. Res, 142, pp.176~191 (2019)
15. Touchefeu Y, "Systematic review : the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis-current evidence and potential clinical applications", Aliment. Pharmacol. Ther, 40, pp.409~421 (2014)
16. Sonis ST, "The pathobiology of mucositis", Nat. Rev. Cancer, 4, pp.277~284 (2004)
17. Montassier E, "Chemotherapy-driven dysbiosis in the intestinal microbiome", Aliment. Pharmacol. Ther, 42, pp.515~528 (2015)
18. Wu CH, "D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation", Ther. Adv. Med. Oncol, 11, pp.1758835918821021~ (2019)
19. Zou YT, "Protective effects of Poria cocos and its components against cisplatininduced intestinal injury", J. Ethnopharmacol, 269, pp.113722~ (2021)
20. Perales-Puchalt A, "Frontline science : Microbiota reconstitution restores intestinal integrity after cisplatin therapy", J. Leukoc. Biol, 103, pp.799~805 (2018)
21. Chiu CJ, "Intestinal mucosal lesion in low-flow states", I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg, 101, pp.478~483 (1970)
22. Shahid F, "Cisplatin-induced gastrointestinal toxicity : An update on possible mechanisms and on available gastroprotective strategies", Eur. J. Pharmacol, 827, pp.49~57 (2018)
23. Bian Y, "Protective effect of Kaempferol on LPS-induced inflammation and barrier dysfunction in a coculture model of intestinal epithelial cells and intestinal microvascular endothelial cells", J. Agric. Food Chem, 68, pp.160~167 (2020)
24. Stojanov S, "The influence of probiotics on the Firmicutes", Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease, 2020, pp.8, 1715~
25. Clemente JC, "The role of the gut microbiome in systemic inflammatory disease", BMJ, 360, pp.j5145~ (2018)
26. Delday M, "Bacteroides thetaiotaomicron Ameliorates colon inflammation in preclinical models of Crohn's disease", Inflamm. Bowel Dis, 25, pp.85~96 (2019)
27. Shin NR, "Proteobacteria : microbial signature of dysbiosis in gut microbiota", Trends Biotechnol, 33, pp.496~503 (2015)
28. Cao R, "Naringin exhibited therapeutic effects against DSS-induced mice ulcerative colitis in intestinal barrier-dependent manner", Molecules, 26, pp.6604~ (2021)
29. Gasaly N, "Butyrate and the fine-tuning of colonic homeostasis : Implication for inflammatory bowel diseases", Int. J. Mol. Sci, 22, pp.3061~ (2021)
30. He Y, "Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+)T cell immunity", Cell Metab, 33, pp.988~1000 (2021)[DOI]
31. Bolte LA, "Long-term dietary patterns are associated with proinflammatory and anti-inflammatory features of the gut microbiome", Gut, 70, pp.1287~1298 (2021)
32. Oh NS, "Cancer-protective effect of a synbiotic combination between Lactobacillus gasseri 505and a Cudrania tricuspidata leaf extract on colitis-associated colorectal cancer", Gut Microbes, 12, pp.1785803~ (2020)
33. Melinda A. Engevik, "Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways", mBio, 10(3) (2019), American Society for Microbiology[DOI]
34. Bianca J. Parker, "The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health", Frontiers in Immunology, 11 (2020), Frontiers Media SA[DOI]
35. Chunsaier Wang, "Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota", BMC Microbiology, 19(1) (2019), Springer Science and Business Media LLC[DOI]
36. Rossi G, "Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease", PLoS One, 9, pp.e94699~ (2014)
37. Ma D, "Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice", Sci. Rep, 8, pp.6670~ (2018)
38. Ju T, "Defining the role of Parasutterella, a previously uncharacterized member of the core gut microbiota", ISME J, 13, pp.1520~1534 (2019)
39. Zhao Z, "Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation", Appl. Microbiol. Biotechnol, 104, pp.5273~5282 (2020)
40. Routy B, "Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors", Science, 359, pp.91~97 (2018)
41. Daisley BA, "Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients", Nat. Commun, 11, pp.4822~ (2020)
42. Mager LF, "Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy", Science, 369, pp.1481~1489 (2020)
43. Zagato E, "Endogenous murine microbiota member Faecalibaculum rodentium and its human homologue protect from intestinal tumour growth", Nat. Microbiol, 5, pp.511~524 (2020)
44. Kelly Nicole Haas, "Kineothrix alysoides, gen. nov., sp. nov., a saccharolytic butyrate-producer within the family Lachnospiraceae", International Journal of Systematic and Evolutionary Microbiology, 67(2), pp.402~410 (2017), Microbiology Society[DOI]
45. Mitsuo Sakamoto, "Lawsonibacter asaccharolyticus gen. nov., sp. nov., a butyrate-producing bacterium isolated from human faeces", International Journal of Systematic and Evolutionary Microbiology, 68(6), pp.2074~2081 (2018), Microbiology Society[DOI]
46. Milosavljevic MN, "Antimicrobial treatment of Erysipelatoclostridium ramosum invasive infections : a systematic review", Rev. Inst. Med. Trop. Sao Paulo, 63, pp.e30~ (2021)
47. Xiao X, "Gut immunity and microbiota dysbiosis are associated with altered bile acid metabolism in LPS-challenged piglets", Oxid. Med. Cell. Longev, 2021, pp.6634821~ (2021)
48. Rehaume LM, "IL-23 favours outgrowth of spondyloarthritisassociated pathobionts and suppresses host support for homeostatic microbiota", Ann. Rheum. Dis, 78, pp.494~503 (2019)
49. Stevens Y, "The intestinal fate of citrus flavanones and their effects on gastrointestinal health", Nutrients, 11, pp.1464~ (2019)
50. Unno T, "Hesperetin modifies the composition of fecal microbiota and increases cecal levels of shortchain fatty acids in rats", J. Agric. Food Chem, 63, pp.7952~7957 (2015)
51. Gong Y, "Neohesperidin prevents colorectal tumorigenesis by altering the gut microbiota", Pharmacol. Res, 148, pp.104460~ (2019)
52. Chen B, "Dietary tangeretin alleviated dextran sulfate sodium-induced colitis in mice via inhibiting inflammatory response, restoring intestinal barrier function, and modulating gut microbiota", J. Agric. Food Chem, 69, pp.7663~7674 (2021)
53. Yan Y, "Chlorogenic acid protects against indomethacin-induced inflammation and mucosa damage by decreasing bacteroides-derived LPS", Front. Immunol, 11, pp.1125~ (2020)
54. Chen J, "Changes of porcine gut microbiota in response to dietary chlorogenic acid supplementation", Appl. Microbiol. Biotechnol, 103, pp.8157~8168 (2019)

관련 논문AI추천